Pedro Ramírez
Tracked across 1 events · 45 articles · First seen Jun 02, 2026 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Pedro Ramírez is the second author of the study, emphasizing the broader health impact of GLP-1 RAs beyond weight management, contributing to his professional standing.
Jun 02, 2026 · 45 articles
90
Pedro Ramírez published study Annals of OncologyGLP-1 Drugs Reduce Cancer Risk
ERGEN INTELLIGENCE
Track Pedro Ramírez live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard